General Information
Version
7.2
Revision date
2025-05-12
Product name
Honokiol
CAS No.
35354-74-6
REACH No
A
Emergency telephone
+56 2 2581 4934
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H411
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Serious eye damage, (Category H318: Causes serious eye damage. 1) Long-term (chronic) aquatic H411: Toxic to aquatic life with long lasting hazard, (Category 2) effects.
Signal word
Danger Danger
Hazard statements
H318 Causes serious eye damage. H411 Toxic to aquatic life with long lasting effects. H318 Causes serious eye damage.
Precautionary statements
P273 Avoid release to the environment. P280 Wear eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P391 Collect spillage. P501 Dispose of contents/ container to an approved waste disposal plant. P280 Wear eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.